Prof. Ying Liao | Animal virus | Best Researcher Award

Shanghai Veterinary Research Institute, Chinese Academy of Agricultutral Science | China.

Author Profile

🎓EARLY ACADEMIC PURSUITS

Prof. Ying Liao began her academic journey with a B.Sc. from East China Normal University (1993–1997), laying the groundwork for her passion in molecular virology and infectious diseases. She further honed her expertise through a Ph.D. in Biological Sciences at Nanyang Technological University, Singapore (2002–2007), where she embarked on groundbreaking research into coronavirus biology and viral-host interactions, setting the tone for a stellar scientific career.

💼PROFESSIONAL ENDEAVORS

Prof. Liao’s professional path reflects her unwavering commitment to virology research and leadership. She held research fellow positions at both Nanyang Technological University and the Institute of Molecular and Cell Biology, A*STAR Singapore, between 2007–2014. In 2014, she joined the Shanghai Veterinary Research Institute (SHVRI) of the Chinese Academy of Agricultural Sciences (CAAS) as a Professor, where she currently serves as Group Leader and Principal Investigator of the Avian Viral Diseases Team. Her team is central to China’s national strategy on animal infectious disease control and vaccine innovation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL VIRUS

Prof. Ying Liao’s research centers on animal virus pathogenesis, especially coronaviruses, flaviviruses, and paramyxoviruses. Her work has made significant contributions in:

Understanding virus-host molecular mechanisms
Dissecting immune evasion pathways
Developing diagnostic tools and antiviral therapeutics
Exploring translational control during infection

Her team uses coronavirus and paramyxovirus models to study innate immunity suppression, stress granule manipulation, and translation shutoff, delivering insights that are not only academically profound but also clinically and agriculturally impactful.

🌍IMPACT AND INFLUENCE

Prof. Liao’s discoveries have broad implications in the fields of veterinary virology, pandemic preparedness, and vaccine design. Her research has informed global scientific understanding of zoonotic diseases and has contributed directly to the development of protective vaccines and antiviral strategies against infectious bronchitis virus (IBV) and Newcastle Disease Virus (NDV). As an internationally respected virologist, she continues to collaborate with leading figures across Asia, Europe, and the Americas, enhancing One Health frameworks worldwide.

🏆RESEARCH GRANTS AND FUNDING

Prof. Ying Liao has successfully led and secured over 12 major research grants, including:

🇨🇳 National Natural Science Foundation of China (NSFC)
🧬 National Key R&D Program of China
🧪 Shanghai Natural Science Foundation
🏛 Chinese Academy of Agricultural Sciences (CAAS) Elite Youth Program
🔬 Public-Interest Scientific Institution Basal Research Fund

Collectively, these projects total millions in funding, empowering extensive research into coronavirus immune evasion, host translation shutoff, stress granules, and avian vaccine development.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Prof. Liao is shaping the future of infectious disease research in China and beyond. Her legacy includes:

The development of a cell line expressing furin protein for avian coronavirus culture (patented)
The training and mentorship of numerous postdoctoral researchers and graduate students
Significant strides toward universal vaccine strategies for coronaviruses
Leadership in the design of molecular diagnostic reagents for rapid outbreak response

Her dedication ensures that her work will outlive current global health challenges and serve as a foundation for next-generation viral therapeutics.

🌟A VISIONARY IN INFECTIOUS DISEASES

A trailblazer in veterinary and molecular virology, Prof. Ying Liao embodies the rare blend of scientific excellence, innovative thinking, and societal relevance. Her relentless pursuit of knowledge in host-pathogen interactions, vaccine innovation, and immune regulation has solidified her role as a visionary leader in infectious diseases. Her strategic foresight and collaborative mindset continue to transform how the scientific community responds to animal and zoonotic viral threats.

📑NOTABLE PUBLICATIONS

🧪Coronavirus endoribonuclease nsp15 suppresses host protein synthesis and evades PKR-eIF2α-mediated translation shutoff to ensure viral protein synthesis

Authors: Gong, Xiaoqian; Feng, Shanhuan; Wang, Jiehuang; Forlenza, Maria; Liao, Ying
Year: 2025
Journal: PLoS Pathogens

🧪Targeting host integrated stress response: lead discovery of flavonoid compounds active against coronaviruses PEDV and PDCoV

Authors: Yi, Liang; Wang, Yishuai; Wang, Jiehuang; Liao, Ying; Zhang, Qingwen
Year: 2024
Journal: RSC Medicinal Chemistry

🧪Newcastle disease virus infection induces parthanatos in tumor cells via calcium waves

Authors: Qu, Yang; Wang, Siyuan; Jiang, Hui; Sun, Yingjie; Ding, Chan
Year: 2024
Journal: PLoS Pathogens

🧪 Coronavirus nucleocapsid protein enhances the binding of p-PKCα to RACK1: Implications for inhibition of nucleocytoplasmic trafficking and suppression of the innate immune response

Authors: Xue, Wenxiang; Chu, Hongyan; Wang, Jiehuang; Ding, Chan; Liao, Ying
Year: 2024
Journal: PLoS Pathogens

🧪FGFR1-mediated enhancement of foot-and-mouth disease virus entry

Authors: Wang, Xuefei; Liao, Ying; Abdullah, Sahibzada Waheed; Sun, Shiqi; Guo, Huichen
Year: 2024
Journal: Veterinary Microbiologyy

Institute of Molecular Genetics of the Czech Academy of Sciences | Czech Republic.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Katerina Trejbalova began her academic journey with a deep interest in veterinary microbiology and infectious diseases. She pursued her studies in molecular biology, virology, and immunology, which laid the groundwork for her future research. Her doctoral research focused on host-pathogen interactions, particularly in animal infectious diseases, equipping her with extensive expertise in disease prevention and control strategies.

💼PROFESSIONAL ENDEAVORS

Dr. Trejbalova has held influential roles in academic institutions, veterinary research centers, and global health organizations. She has worked extensively in disease surveillance, vaccine development, and epidemiological studies. As a researcher, educator, and mentor, she has significantly contributed to shaping the next generation of scientists in veterinary infectious diseases and public health.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL INFECTIOUS DISEASES

Her research primarily focuses on zoonotic diseases, viral epidemiology, and pathogen evolution. Dr. Trejbalova has made significant contributions to the early detection of viral outbreaks, vaccine efficacy studies, and molecular diagnostics. She has worked on novel therapeutic interventions for highly contagious livestock diseases, aiding in pandemic preparedness and disease eradication programs.

🌍IMPACT AND INFLUENCE

Dr. Trejbalova’s work has had a profound global impact on animal health policies, veterinary public health, and biosecurity initiatives. She has collaborated with international research institutions and governmental bodies to develop strategies for controlling infectious diseases in livestock and wildlife. Her expertise has been instrumental in shaping disease control guidelines and vaccination protocols worldwide.

📚ACADEMIC CITATIONS

Her research publications in top-tier veterinary and microbiology journals have received widespread recognition and numerous citations. Dr. Trejbalova’s studies are frequently referenced in epidemiological research, virology, and disease management, solidifying her reputation as a leading authority in infectious disease research.

🏆RESEARCH GRANTS AND FUNDING

Dr. Trejbalova has successfully secured competitive research grants from prestigious funding agencies to support her work in viral pathogenesis, disease modeling, and advanced diagnostic techniques. Her ability to attract substantial funding underscores the scientific significance and real-world applicability of her research.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Trejbalova’s legacy is defined by her groundbreaking contributions to veterinary medicine and infectious disease control. She continues to explore genetic factors influencing disease susceptibility, next-generation vaccine formulations, and AI-driven disease tracking systems. Her future research aims to enhance global disease preparedness and improve the resilience of veterinary healthcare systems.

🌟A VISIONARY IN INFECTIOUS DISEASES

As a pioneer in veterinary microbiology, Dr. Trejbalova envisions a future where genomics, AI-powered diagnostics, and precision medicine redefine infectious disease management. Her unwavering dedication to scientific innovation and global health security establishes her as a trailblazer in the field.

📑NOTABLE PUBLICATIONS

Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta

Authors: K. Štafl, Kryštof; M. Trávníček, Martin; A. Janovska, Anna; J. Hejnar, Jiří; K. Trejbalová, Kateřina
Publication Year: 2024
Journal: Proceedings of the National Academy of Sciences of the United States of America (PNAS)

Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

Authors: J. Trousil, Jiří; N.J.K. Dal, Nils Jørgen Knudsen; F. Fenaroli, Federico; O. Pavliš, Ota; A.D. Sosnik, Alejandro D.
Publication Year: 2022
Citations: 13